MLYS
Mineralys Therapeutics, Inc.
22.40$
+1.3%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
Mineralys Therapeutics, Inc. (MLYS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -33 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.9 | -6.6 | -5.5 | -7.0 | -10 | -13 | -20 | -19 | -29 | -19 | -30 | -50 | -67 | -45 | -30 | -29 | -38 | -39 | -33 | -139 | |
| – | – | – | – | – | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.7 | 1.3 | 1.6 | 1.5 | 2.2 | 0.0 | 3.1 | 3.1 | 3.6 | 4.6 | 5.8 | 5.3 | 6.5 | 7.4 | 25 | |
| – | – | 0.0 | – | -0.2 | -0.7 | -0.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.2 | 0.1 | 0.0 | -0.5 | -0.9 | -0.1 | -7.5 | 4.1 | -4.0 | 13 | 11 | 5.7 | -20 | -5.9 | 11 | 4.6 | -6.7 | -2.1 | 5.7 | 1.5 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | 50 | -72 | 50 | -140 | -16 | 4.0 | -8.1 | -56 | 7.7 | 80 | 84 | -93 | -43 | -151 | -103 | -45 | -185 | -484 | |
| – | – | – | – | – | – | 0.0 | – | 0.1 | – | – | 0.1 | – | – | 0.1 | – | 0.1 | – | 0.3 | – | |
| 0.0 | 12 | 118 | -0.6 | -1.1 | 204 | -0.6 | 0.2 | 0.1 | 116 | -0.2 | 0.0 | 0.1 | 189 | 9.8 | 295 | 97 | 24 | 243 | 659 | |
| -4.9 | 5.4 | 112 | -79 | 39 | 51 | -37 | -15 | -37 | 41 | -23 | 29 | 17 | 51 | -63 | 116 | -45 | -60 | 25 | 36 | |
| -4.9 | -6.6 | -5.5 | -7.0 | -10 | -13 | -20 | -19 | -29 | -19 | -30 | -50 | -67 | -45 | -30 | -29 | -38 | -39 | -33 | -139 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.